Nelson, M. H., Bowers, J. S., Bailey, S. R., Diven, M. A., Fugle, C. W., Kaiser, A. D. M., . . . Paulos, C. M. (2016). Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning. BioMed Central.
Chicago Style CitationNelson, Michelle H., et al. Toll-like Receptor Agonist Therapy Can Profoundly Augment the Antitumor Activity of Adoptively Transferred CD8+ T Cells Without Host Preconditioning. BioMed Central, 2016.
MLA CitationNelson, Michelle H., et al. Toll-like Receptor Agonist Therapy Can Profoundly Augment the Antitumor Activity of Adoptively Transferred CD8+ T Cells Without Host Preconditioning. BioMed Central, 2016.
Warning: These citations may not always be 100% accurate.